Zobrazeno 1 - 10
of 1 060
pro vyhledávání: '"R, Modigliani"'
Autor:
V. CANVA-DELCAMBRE, S. JACQUOT, E. ROBINET, M. LÉMANN, C. DROUET, M. LABALETTE, J.-P. DESSAINT, D. ENGOUFA, B C. RABIAN, R. MODIGLIANI, J. WIJDENES, J.-P. REVILLARD, J.-F. COLOMBEL
Publikováno v:
Alimentary Pharmacology & Therapeutics. 10:721-727
Background: Monoclonal CD4 antibodies have been proposed as a new immunosuppressant drug in the treatment of inflammatory bowel disease. We report our experience of treatment with a monoclonal anti-CD4 (B-F5) antibody in severe refractory Crohn's dis
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c02e50bb7306a71fc3b5e54c768bc6fb
https://doi.org/10.1046/j.1365-2036.1996.59201000.x
https://doi.org/10.1046/j.1365-2036.1996.59201000.x
Publikováno v:
Inflammatory bowel diseases. 1(4)
Summary: Olsalazine, consisting of two salicylate radicals linked by an azo-bond, is effective in the treatment of active ulcerative colitis. To test its effect in patients with mild to moderate attacks of Crohn’s disease, the International Organiz
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8903b2d33671fc19207983e3bef7a331
https://pubmed.ncbi.nlm.nih.gov/23282422
https://pubmed.ncbi.nlm.nih.gov/23282422
Autor:
Jp. Vaerman, R. Modigliani, E. Wain, J-F Colombel, R. Hallgren, Jean-Pierre Dehennin, Antoine Cortot
Publikováno v:
Gut. 33:44-47
The aim of this work was to study the jejunal secretion of immunoglobulins (Ig), albumin, and hyaluronan in response to jejunal perfusion of an elemental diet. A four lumen tube with a proximal occluding balloon at the angle of Treitz was used for je
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::773c7e593d59c7193ea2b58a1b280bde
https://doi.org/10.1136/gut.33.1.44
https://doi.org/10.1136/gut.33.1.44
Autor:
M, Campieri, T, Gilat, S, Hanauer, B, Korelitz, K, Lauritsen, H, Malchow, F, Martin, M, Miglioli, R, Modigliani, D, Present, J, Schölmerich, L, Sutherland
Publikováno v:
Inflammatory Bowel Diseases. 2:265-267
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::39c9fc3000d8ec02fec16a44b1b5c22b
https://doi.org/10.1097/00054725-199612000-00007
https://doi.org/10.1097/00054725-199612000-00007
Autor:
J-M, Gornet, S, Couve, Z, Hassani, J-C, Delchier, P, Marteau, J, Cosnes, Y, Bouhnik, J-L, Dupas, R, Modigliani, F, Taillard, M, Lemann
Publikováno v:
Alimentary pharmacologytherapeutics. 18(2)
The efficacy of infliximab in ulcerative colitis (UC) and indeterminate colitis has been poorly assessed and preliminary results are conflicting.The records of 30 patients treated with infliximab for ulcerative colitis (n=19) or indeterminate colitis
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::a974eb9729ec76e3896e544461ce50b4
https://pubmed.ncbi.nlm.nih.gov/12869077
https://pubmed.ncbi.nlm.nih.gov/12869077
Publikováno v:
Alimentary pharmacologytherapeutics. 16(6)
Infliximab, a chimeric monoclonal antibody to tumour necrosis factor-alpha, is a new potent therapy for active Crohn's disease, but induces short-lived improvements.To evaluate the efficacy of thalidomide, a drug with anti-tumour necrosis factor-alph
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::811730dbf3dc93ecd046f37bb8a36ddb
https://pubmed.ncbi.nlm.nih.gov/12030953
https://pubmed.ncbi.nlm.nih.gov/12030953
Autor:
A, Ouraghi, S, Nieuviarts, J L, Mougenel, M, Allez, M, Barthet, F, Carbonnel, J, Cosnes, J P, Gendre, B, Flourié, J J, Meurisse, P, Quandalle, O, Ernst, M, Lemann, A, Cortot, R, Modigliani, J F, Colombel
Publikováno v:
Gastroenterologie clinique et biologique. 25(11)
To retrospectively evaluate the efficacy, the duration of response, and the tolerance of Remicade in anoperineal Crohn's disease.Fifty patients with severe symptomatic and refractory anoperineal Crohn's lesions (38 fistulae and 29 cavitating ulcers a
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::655dc1bf469e6fc0beeedf40409ecb9b
https://pubmed.ncbi.nlm.nih.gov/11845043
https://pubmed.ncbi.nlm.nih.gov/11845043
Publikováno v:
The Cochrane database of systematic reviews. (3)
To evaluate the effectiveness and safety of conventional systemic corticosteroid therapy in maintaining clinical remission in Crohn's disease.A computer-assisted search of the on-line bibliographic database MEDLINE of studies published in English, Fr
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid_dedup__::7fcb9326a634a5be4051bdd2072ad157
https://pubmed.ncbi.nlm.nih.gov/14583917
https://pubmed.ncbi.nlm.nih.gov/14583917
Autor:
N, Patey-Mariaud De Serre, C, Cellier, B, Jabri, E, Delabesse, V, Verkarre, B, Roche, A, Lavergne, J, Brière, L, Mauvieux, M, Leborgne, J P, Barbier, R, Modigliani, C, Matuchansky, E, MacIntyre, N, Cerf-Bensussan, N, Brousse
Publikováno v:
Histopathology. 37(1)
We recently showed that refractory sprue is distinct from coeliac disease, the former being characterized by abnormal intraepithelial T-lymphocytes expressing a cytoplasmic CD3 chain (CD3c), lacking CD3 and CD8 surface expression, and showing TCRgamm
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::c860172732bac64ccb3fb41f927a15f1
https://pubmed.ncbi.nlm.nih.gov/10931221
https://pubmed.ncbi.nlm.nih.gov/10931221
Autor:
R, Modigliani
Publikováno v:
Gastroenterologie clinique et biologique. 23(5 Pt 2)
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::6662706346990d45508945919721df9f
https://pubmed.ncbi.nlm.nih.gov/10897789
https://pubmed.ncbi.nlm.nih.gov/10897789